Pyxis Oncology raised to outperform rating by William Blair
PYXS•William Blair raised its rating on Pyxis Oncology to outperform.
Related News

Modular Medical CEO James E. Besser reports acquisition of $20,256 in common shares
MODD•

Australian dollar hits 11-month low, kiwi at six-year trough
TLT•

Loblaw Companies raises target price to C$84 from C$83
L•

Gold set for worst week in eight months as firm dollar, Fed hike bets weigh
GLD•

TSMC tightens China AI chip curbs as new US rules close manufacturing loophole, sources say
TSM•